NCT02043808View on ClinicalTrials.gov

The Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-Valvular Atrial Fibrillation Population With DoD Healthcare Coverage

CompletedOBSERVATIONAL
Enrollment

25,586

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Atrial Fibrillation
Trial Locations (1)

Unknown

1160.183.01 Boehringer Ingelheim Investigational Site, Lexington

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY